Recognizing that PSA remains the most sensitive screening test available for the early detection of prostate cancer, 9, 10 a better understanding of the relationship between serum testosterone and PSA ...
Second-line everolimus treatment is effective in RCC patients with poor progression-free survival (PFS) in first-line VEGF-targeted therapies. This is an ASCO Meeting Abstract from the 2011 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback